|
SLS Sellas Life Sciences Group Inc 1390478 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-8,407,000.00 |
| Balance Sheet |
|
Current Assets
|
$111,169,000.00 |
|
Assets
|
$114,177,000.00 |
|
Current Liabilities
|
$6,456,000.00 |
|
Liabilities
|
$6,765,000.00 |
|
Equity
|
$107,412,000.00 |
|
Shares Out
|
181332574.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,846,000.00 |
| Market Analysis |
Market Cap
|
$1,865,912,186.46 |
|
Price
|
$9.96 |
|
BVPS
|
0.59 |
|
PB
|
17.44 |
|
EPS
|
-0.05 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
-0.25 |
|
|
2026-05-12 |
-0.05 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.07 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLS documents filed with the SEC.
SLS Filings
Clear
